Microbiome-associated therapeutic strategies for modulating cancer treatment.
Interventional approaches targeting the gut microbiome to engineer a more desirable landscape for improving the outcome of cancer immunotherapeutics. Strategies to shape the gut microbiome include using specific bacterial consortia or probiotic supplementation, transfer of fecal microbiota, addition of specific bacterial organisms, and implementing a defined diet. Created using BioRender.com.